申请人:GENZYME CORPORATION
公开号:US20150210681A1
公开(公告)日:2015-07-30
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
本发明涉及一种葡糖酰胺合酶(GCS)抑制剂,可用于治疗代谢性疾病,如溶酶体贮存病,单独或与酶替代疗法、囊性疾病联合使用,以及用于治疗癌症。